HOME >> BIOLOGY >> NEWS
16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

The 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics brings 2,000 international cancer experts together to present new data on leading-edge basic, translational and early clinical research.

News briefing:

12.30 hrs CET Wednesday 29 September:

Speakers and topics

    * Dr Monika Hegi: Trial identifies which brain cancer patients benefit from temozolomide: genetic predictive test can be carried out in any laboratory and means temozolomide can now become a targeted treatment.

    * Dr Ardeshir Ghavamzadeh: Trial results indicate arsenic should now be considered first-line treatment for one type of leukaemia

    *Dr Kim Chi: Successful results of Phase I trial of the first second generation antisense cancer drug - phase II getting under way

    * Dr Grant McArthur: Award winning researcher reveals potential new role for Glivec in a soft tissue cancer

Chairman: Professor Jaap Verweij (EORTC chairman of conference scientific committee) together with scientific committee co-chairmen Dr Janet Dancey (NCI) and Dr Eric K Rowinsky (AACR)

NB: any reports involving the topics outlined above are embargoed until the time and date of the news briefings.

Journalists wishing to dial in to the news briefing should contact Margaret Willson by Friday 25 September.

More information:

Margaret Willson
Conference Press Officer

Tel: 44-153-677-2181 (office)
44-797-385-3347 (mobile)
Email: m.willson@mwcommunications.org.uk

Conference media centre:
From 16.00 hrs CET Monday 27 September to 17.00 hrs CET Friday 1 October
Tel: 41-22-761-2205
Fax: 41-22-761-2211


'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-015-367-72181
European Organisation for Research and Treatment of Cancer
22-Sep-2004


Page: 1

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. Health of worlds sea lions the focus of Wakefield Symposium
4. Chemical signals health of brain cells Symposium
5. Final Alert: 16th EORTC NCI AACR Symposium
6. 16th EORTC NCI AACR Symposium
7. Symposium to tackle questions of genetic engineering and biodiversity
8. Fostering Diversity in the Sciences Symposium
9. Annual Chemical Biology Symposium at Yale May 14, 2004
10. Symposium relates long-term ecological research to ecosystem management
11. Symposium examines the growing influence of aerosols on climate

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... ... voice recognition biometrics market to grow at a CAGR of 19.36% ... present scenario and the growth prospects of the global voice recognition ... considers the revenue generated from the sales of voice recognition biometrics ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical and ... previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented on ...
(Date:2/24/2017)... Tenn. , Feb. 24, 2017 ... ("Provectus" or the "Company"), a clinical-stage oncology and ... regarding the deadline to participate in its previously ... units, consisting of shares of common stock and ... and holders of listed warrants. ...
(Date:2/24/2017)... 24, 2017  Driven by consumers, preference towards ... the fastest growing categories, finds the recently published ... Personal Care: Multi-regional Market Analysis and Opportunities ... firm Kline. "Biotechnology actives are derived ... more effective for skin and hair care applications," ...
Breaking Biology Technology:
Cached News: